Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorypeptidesfdakennedysupplements

Study Documents Rising Use of Unapproved 'Wolverine' Peptide

Reuters reports increased consumer uptake of the untested peptide publicly supported by the US Health Secretary.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 15 17:50 ETSource: reuters.com

The wire

  1. 01A new study finds growing use of an untested peptide backed by Health Secretary Kennedy.
  2. 02Raises oversight questions for peptides sold outside FDA approval pathways.
  3. 03Clinical risk profile and regulatory next steps remain unknown.

From the source

Use of untested 'Wolverine' peptide backed by US Health Secretary Kennedy on the rise, study finds

Read at news.google.com